Suffolk Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-25,161
| Closed | -$691K | – | 147 |
|
|
2018
Q2 | $691K | Hold |
25,161
| – | – | 0.1% | 100 |
|
|
2018
Q1 | $775K | Buy |
25,161
+1,500
| +6% | +$46.2K | 0.11% | 100 |
|
|
2017
Q4 | $846K | Sell |
23,661
-29,436
| -55% | -$1.05M | 0.11% | 92 |
|
|
2017
Q3 | $1.46M | Sell |
53,097
-16,998
| -24% | -$468K | 0.19% | 64 |
|
|
2017
Q2 | $1.85M | Sell |
70,095
-13,400
| -16% | -$354K | 0.24% | 62 |
|
|
2017
Q1 | $1.74M | Sell |
83,495
-7,699
| -8% | -$160K | 0.23% | 58 |
|
|
2016
Q4 | $1.89M | Hold |
91,194
| – | – | 0.26% | 62 |
|
|
2016
Q3 | $1.48M | Sell |
91,194
-67,618
| -43% | -$1.1M | 0.2% | 92 |
|
|
2016
Q2 | $2.16M | Buy |
158,812
+62,341
| +65% | +$848K | 0.28% | 113 |
|
|
2016
Q1 | $1.68M | Buy |
96,471
+48,513
| +101% | +$847K | 0.22% | 124 |
|
|
2015
Q4 | $1.64M | Buy |
+47,958
| New | +$1.64M | 0.21% | 127 |
|